While most clinicians focus on weight loss and glucose lowering, new data on GLP-1 microbiome effects suggest something deeper may be happening in the gut
In addition to glycemic control and weight loss, certain GLP-1 receptor agonists have FDA-approved indications to lower the risk for major adverse cardiovascular events, address moderate to severe obstructive sleep apnea, and, most recently, reduce the risk for worsening kidney disease, kidney failure, and cardiovascular death
This protocol summarizes the types and causes of dizziness and vertigo and the different treatment strategies available, including repositioning techniques to remove debris from the inner ear either at home or at the doctors office
Not only toxicology, OoCs are being validated against patient-specific clinical data
Phytomedicine, 34 , 26-37